Global Subcutaneous Allergy Immunotherapies Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 98

Published Date: 09 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

According to our (Global Info Research) latest study, the global Subcutaneous Allergy Immunotherapies market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Subcutaneous Allergy Immunotherapies market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Subcutaneous Allergy Immunotherapies market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Subcutaneous Allergy Immunotherapies market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Subcutaneous Allergy Immunotherapies market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Subcutaneous Allergy Immunotherapies market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Subcutaneous Allergy Immunotherapies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Subcutaneous Allergy Immunotherapies market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics and HAL, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Subcutaneous Allergy Immunotherapies market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    High Concentration
    Low Concentration

Market segment by Application
    Primary Immunodeficiency
    Secondary Immunodeficiency
    Others

Major players covered
    ALK-Abello
    Stallergenes Greer
    Merck
    Allergy Therapeutics
    HAL
    WOLW Pharma
    Holister Stier
    Leti

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Subcutaneous Allergy Immunotherapies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Subcutaneous Allergy Immunotherapies, with price, sales, revenue and global market share of Subcutaneous Allergy Immunotherapies from 2018 to 2023.
Chapter 3, the Subcutaneous Allergy Immunotherapies competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Subcutaneous Allergy Immunotherapies breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Subcutaneous Allergy Immunotherapies market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Subcutaneous Allergy Immunotherapies.
Chapter 14 and 15, to describe Subcutaneous Allergy Immunotherapies sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Subcutaneous Allergy Immunotherapies
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Subcutaneous Allergy Immunotherapies Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 High Concentration
        1.3.3 Low Concentration
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Subcutaneous Allergy Immunotherapies Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Primary Immunodeficiency
        1.4.3 Secondary Immunodeficiency
        1.4.4 Others
    1.5 Global Subcutaneous Allergy Immunotherapies Market Size & Forecast
        1.5.1 Global Subcutaneous Allergy Immunotherapies Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Subcutaneous Allergy Immunotherapies Sales Quantity (2018-2029)
        1.5.3 Global Subcutaneous Allergy Immunotherapies Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 ALK-Abello
        2.1.1 ALK-Abello Details
        2.1.2 ALK-Abello Major Business
        2.1.3 ALK-Abello Subcutaneous Allergy Immunotherapies Product and Services
        2.1.4 ALK-Abello Subcutaneous Allergy Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 ALK-Abello Recent Developments/Updates
    2.2 Stallergenes Greer
        2.2.1 Stallergenes Greer Details
        2.2.2 Stallergenes Greer Major Business
        2.2.3 Stallergenes Greer Subcutaneous Allergy Immunotherapies Product and Services
        2.2.4 Stallergenes Greer Subcutaneous Allergy Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Stallergenes Greer Recent Developments/Updates
    2.3 Merck
        2.3.1 Merck Details
        2.3.2 Merck Major Business
        2.3.3 Merck Subcutaneous Allergy Immunotherapies Product and Services
        2.3.4 Merck Subcutaneous Allergy Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Merck Recent Developments/Updates
    2.4 Allergy Therapeutics
        2.4.1 Allergy Therapeutics Details
        2.4.2 Allergy Therapeutics Major Business
        2.4.3 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Product and Services
        2.4.4 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Allergy Therapeutics Recent Developments/Updates
    2.5 HAL
        2.5.1 HAL Details
        2.5.2 HAL Major Business
        2.5.3 HAL Subcutaneous Allergy Immunotherapies Product and Services
        2.5.4 HAL Subcutaneous Allergy Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 HAL Recent Developments/Updates
    2.6 WOLW Pharma
        2.6.1 WOLW Pharma Details
        2.6.2 WOLW Pharma Major Business
        2.6.3 WOLW Pharma Subcutaneous Allergy Immunotherapies Product and Services
        2.6.4 WOLW Pharma Subcutaneous Allergy Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 WOLW Pharma Recent Developments/Updates
    2.7 Holister Stier
        2.7.1 Holister Stier Details
        2.7.2 Holister Stier Major Business
        2.7.3 Holister Stier Subcutaneous Allergy Immunotherapies Product and Services
        2.7.4 Holister Stier Subcutaneous Allergy Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Holister Stier Recent Developments/Updates
    2.8 Leti
        2.8.1 Leti Details
        2.8.2 Leti Major Business
        2.8.3 Leti Subcutaneous Allergy Immunotherapies Product and Services
        2.8.4 Leti Subcutaneous Allergy Immunotherapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Leti Recent Developments/Updates

3 Competitive Environment: Subcutaneous Allergy Immunotherapies by Manufacturer
    3.1 Global Subcutaneous Allergy Immunotherapies Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Subcutaneous Allergy Immunotherapies Revenue by Manufacturer (2018-2023)
    3.3 Global Subcutaneous Allergy Immunotherapies Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Subcutaneous Allergy Immunotherapies by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Subcutaneous Allergy Immunotherapies Manufacturer Market Share in 2022
        3.4.2 Top 6 Subcutaneous Allergy Immunotherapies Manufacturer Market Share in 2022
    3.5 Subcutaneous Allergy Immunotherapies Market: Overall Company Footprint Analysis
        3.5.1 Subcutaneous Allergy Immunotherapies Market: Region Footprint
        3.5.2 Subcutaneous Allergy Immunotherapies Market: Company Product Type Footprint
        3.5.3 Subcutaneous Allergy Immunotherapies Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Subcutaneous Allergy Immunotherapies Market Size by Region
        4.1.1 Global Subcutaneous Allergy Immunotherapies Sales Quantity by Region (2018-2029)
        4.1.2 Global Subcutaneous Allergy Immunotherapies Consumption Value by Region (2018-2029)
        4.1.3 Global Subcutaneous Allergy Immunotherapies Average Price by Region (2018-2029)
    4.2 North America Subcutaneous Allergy Immunotherapies Consumption Value (2018-2029)
    4.3 Europe Subcutaneous Allergy Immunotherapies Consumption Value (2018-2029)
    4.4 Asia-Pacific Subcutaneous Allergy Immunotherapies Consumption Value (2018-2029)
    4.5 South America Subcutaneous Allergy Immunotherapies Consumption Value (2018-2029)
    4.6 Middle East and Africa Subcutaneous Allergy Immunotherapies Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Subcutaneous Allergy Immunotherapies Sales Quantity by Type (2018-2029)
    5.2 Global Subcutaneous Allergy Immunotherapies Consumption Value by Type (2018-2029)
    5.3 Global Subcutaneous Allergy Immunotherapies Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Subcutaneous Allergy Immunotherapies Sales Quantity by Application (2018-2029)
    6.2 Global Subcutaneous Allergy Immunotherapies Consumption Value by Application (2018-2029)
    6.3 Global Subcutaneous Allergy Immunotherapies Average Price by Application (2018-2029)

7 North America
    7.1 North America Subcutaneous Allergy Immunotherapies Sales Quantity by Type (2018-2029)
    7.2 North America Subcutaneous Allergy Immunotherapies Sales Quantity by Application (2018-2029)
    7.3 North America Subcutaneous Allergy Immunotherapies Market Size by Country
        7.3.1 North America Subcutaneous Allergy Immunotherapies Sales Quantity by Country (2018-2029)
        7.3.2 North America Subcutaneous Allergy Immunotherapies Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Subcutaneous Allergy Immunotherapies Sales Quantity by Type (2018-2029)
    8.2 Europe Subcutaneous Allergy Immunotherapies Sales Quantity by Application (2018-2029)
    8.3 Europe Subcutaneous Allergy Immunotherapies Market Size by Country
        8.3.1 Europe Subcutaneous Allergy Immunotherapies Sales Quantity by Country (2018-2029)
        8.3.2 Europe Subcutaneous Allergy Immunotherapies Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Subcutaneous Allergy Immunotherapies Market Size by Region
        9.3.1 Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Subcutaneous Allergy Immunotherapies Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Subcutaneous Allergy Immunotherapies Sales Quantity by Type (2018-2029)
    10.2 South America Subcutaneous Allergy Immunotherapies Sales Quantity by Application (2018-2029)
    10.3 South America Subcutaneous Allergy Immunotherapies Market Size by Country
        10.3.1 South America Subcutaneous Allergy Immunotherapies Sales Quantity by Country (2018-2029)
        10.3.2 South America Subcutaneous Allergy Immunotherapies Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Subcutaneous Allergy Immunotherapies Market Size by Country
        11.3.1 Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Subcutaneous Allergy Immunotherapies Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Subcutaneous Allergy Immunotherapies Market Drivers
    12.2 Subcutaneous Allergy Immunotherapies Market Restraints
    12.3 Subcutaneous Allergy Immunotherapies Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Subcutaneous Allergy Immunotherapies and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Subcutaneous Allergy Immunotherapies
    13.3 Subcutaneous Allergy Immunotherapies Production Process
    13.4 Subcutaneous Allergy Immunotherapies Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Subcutaneous Allergy Immunotherapies Typical Distributors
    14.3 Subcutaneous Allergy Immunotherapies Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Subcutaneous Allergy Immunotherapies Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Subcutaneous Allergy Immunotherapies Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. ALK-Abello Basic Information, Manufacturing Base and Competitors
    Table 4. ALK-Abello Major Business
    Table 5. ALK-Abello Subcutaneous Allergy Immunotherapies Product and Services
    Table 6. ALK-Abello Subcutaneous Allergy Immunotherapies Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. ALK-Abello Recent Developments/Updates
    Table 8. Stallergenes Greer Basic Information, Manufacturing Base and Competitors
    Table 9. Stallergenes Greer Major Business
    Table 10. Stallergenes Greer Subcutaneous Allergy Immunotherapies Product and Services
    Table 11. Stallergenes Greer Subcutaneous Allergy Immunotherapies Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Stallergenes Greer Recent Developments/Updates
    Table 13. Merck Basic Information, Manufacturing Base and Competitors
    Table 14. Merck Major Business
    Table 15. Merck Subcutaneous Allergy Immunotherapies Product and Services
    Table 16. Merck Subcutaneous Allergy Immunotherapies Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Merck Recent Developments/Updates
    Table 18. Allergy Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 19. Allergy Therapeutics Major Business
    Table 20. Allergy Therapeutics Subcutaneous Allergy Immunotherapies Product and Services
    Table 21. Allergy Therapeutics Subcutaneous Allergy Immunotherapies Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Allergy Therapeutics Recent Developments/Updates
    Table 23. HAL Basic Information, Manufacturing Base and Competitors
    Table 24. HAL Major Business
    Table 25. HAL Subcutaneous Allergy Immunotherapies Product and Services
    Table 26. HAL Subcutaneous Allergy Immunotherapies Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. HAL Recent Developments/Updates
    Table 28. WOLW Pharma Basic Information, Manufacturing Base and Competitors
    Table 29. WOLW Pharma Major Business
    Table 30. WOLW Pharma Subcutaneous Allergy Immunotherapies Product and Services
    Table 31. WOLW Pharma Subcutaneous Allergy Immunotherapies Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. WOLW Pharma Recent Developments/Updates
    Table 33. Holister Stier Basic Information, Manufacturing Base and Competitors
    Table 34. Holister Stier Major Business
    Table 35. Holister Stier Subcutaneous Allergy Immunotherapies Product and Services
    Table 36. Holister Stier Subcutaneous Allergy Immunotherapies Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Holister Stier Recent Developments/Updates
    Table 38. Leti Basic Information, Manufacturing Base and Competitors
    Table 39. Leti Major Business
    Table 40. Leti Subcutaneous Allergy Immunotherapies Product and Services
    Table 41. Leti Subcutaneous Allergy Immunotherapies Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Leti Recent Developments/Updates
    Table 43. Global Subcutaneous Allergy Immunotherapies Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 44. Global Subcutaneous Allergy Immunotherapies Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 45. Global Subcutaneous Allergy Immunotherapies Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 46. Market Position of Manufacturers in Subcutaneous Allergy Immunotherapies, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 47. Head Office and Subcutaneous Allergy Immunotherapies Production Site of Key Manufacturer
    Table 48. Subcutaneous Allergy Immunotherapies Market: Company Product Type Footprint
    Table 49. Subcutaneous Allergy Immunotherapies Market: Company Product Application Footprint
    Table 50. Subcutaneous Allergy Immunotherapies New Market Entrants and Barriers to Market Entry
    Table 51. Subcutaneous Allergy Immunotherapies Mergers, Acquisition, Agreements, and Collaborations
    Table 52. Global Subcutaneous Allergy Immunotherapies Sales Quantity by Region (2018-2023) & (K Units)
    Table 53. Global Subcutaneous Allergy Immunotherapies Sales Quantity by Region (2024-2029) & (K Units)
    Table 54. Global Subcutaneous Allergy Immunotherapies Consumption Value by Region (2018-2023) & (USD Million)
    Table 55. Global Subcutaneous Allergy Immunotherapies Consumption Value by Region (2024-2029) & (USD Million)
    Table 56. Global Subcutaneous Allergy Immunotherapies Average Price by Region (2018-2023) & (US$/Unit)
    Table 57. Global Subcutaneous Allergy Immunotherapies Average Price by Region (2024-2029) & (US$/Unit)
    Table 58. Global Subcutaneous Allergy Immunotherapies Sales Quantity by Type (2018-2023) & (K Units)
    Table 59. Global Subcutaneous Allergy Immunotherapies Sales Quantity by Type (2024-2029) & (K Units)
    Table 60. Global Subcutaneous Allergy Immunotherapies Consumption Value by Type (2018-2023) & (USD Million)
    Table 61. Global Subcutaneous Allergy Immunotherapies Consumption Value by Type (2024-2029) & (USD Million)
    Table 62. Global Subcutaneous Allergy Immunotherapies Average Price by Type (2018-2023) & (US$/Unit)
    Table 63. Global Subcutaneous Allergy Immunotherapies Average Price by Type (2024-2029) & (US$/Unit)
    Table 64. Global Subcutaneous Allergy Immunotherapies Sales Quantity by Application (2018-2023) & (K Units)
    Table 65. Global Subcutaneous Allergy Immunotherapies Sales Quantity by Application (2024-2029) & (K Units)
    Table 66. Global Subcutaneous Allergy Immunotherapies Consumption Value by Application (2018-2023) & (USD Million)
    Table 67. Global Subcutaneous Allergy Immunotherapies Consumption Value by Application (2024-2029) & (USD Million)
    Table 68. Global Subcutaneous Allergy Immunotherapies Average Price by Application (2018-2023) & (US$/Unit)
    Table 69. Global Subcutaneous Allergy Immunotherapies Average Price by Application (2024-2029) & (US$/Unit)
    Table 70. North America Subcutaneous Allergy Immunotherapies Sales Quantity by Type (2018-2023) & (K Units)
    Table 71. North America Subcutaneous Allergy Immunotherapies Sales Quantity by Type (2024-2029) & (K Units)
    Table 72. North America Subcutaneous Allergy Immunotherapies Sales Quantity by Application (2018-2023) & (K Units)
    Table 73. North America Subcutaneous Allergy Immunotherapies Sales Quantity by Application (2024-2029) & (K Units)
    Table 74. North America Subcutaneous Allergy Immunotherapies Sales Quantity by Country (2018-2023) & (K Units)
    Table 75. North America Subcutaneous Allergy Immunotherapies Sales Quantity by Country (2024-2029) & (K Units)
    Table 76. North America Subcutaneous Allergy Immunotherapies Consumption Value by Country (2018-2023) & (USD Million)
    Table 77. North America Subcutaneous Allergy Immunotherapies Consumption Value by Country (2024-2029) & (USD Million)
    Table 78. Europe Subcutaneous Allergy Immunotherapies Sales Quantity by Type (2018-2023) & (K Units)
    Table 79. Europe Subcutaneous Allergy Immunotherapies Sales Quantity by Type (2024-2029) & (K Units)
    Table 80. Europe Subcutaneous Allergy Immunotherapies Sales Quantity by Application (2018-2023) & (K Units)
    Table 81. Europe Subcutaneous Allergy Immunotherapies Sales Quantity by Application (2024-2029) & (K Units)
    Table 82. Europe Subcutaneous Allergy Immunotherapies Sales Quantity by Country (2018-2023) & (K Units)
    Table 83. Europe Subcutaneous Allergy Immunotherapies Sales Quantity by Country (2024-2029) & (K Units)
    Table 84. Europe Subcutaneous Allergy Immunotherapies Consumption Value by Country (2018-2023) & (USD Million)
    Table 85. Europe Subcutaneous Allergy Immunotherapies Consumption Value by Country (2024-2029) & (USD Million)
    Table 86. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Quantity by Type (2018-2023) & (K Units)
    Table 87. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Quantity by Type (2024-2029) & (K Units)
    Table 88. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Quantity by Application (2018-2023) & (K Units)
    Table 89. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Quantity by Application (2024-2029) & (K Units)
    Table 90. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Quantity by Region (2018-2023) & (K Units)
    Table 91. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Quantity by Region (2024-2029) & (K Units)
    Table 92. Asia-Pacific Subcutaneous Allergy Immunotherapies Consumption Value by Region (2018-2023) & (USD Million)
    Table 93. Asia-Pacific Subcutaneous Allergy Immunotherapies Consumption Value by Region (2024-2029) & (USD Million)
    Table 94. South America Subcutaneous Allergy Immunotherapies Sales Quantity by Type (2018-2023) & (K Units)
    Table 95. South America Subcutaneous Allergy Immunotherapies Sales Quantity by Type (2024-2029) & (K Units)
    Table 96. South America Subcutaneous Allergy Immunotherapies Sales Quantity by Application (2018-2023) & (K Units)
    Table 97. South America Subcutaneous Allergy Immunotherapies Sales Quantity by Application (2024-2029) & (K Units)
    Table 98. South America Subcutaneous Allergy Immunotherapies Sales Quantity by Country (2018-2023) & (K Units)
    Table 99. South America Subcutaneous Allergy Immunotherapies Sales Quantity by Country (2024-2029) & (K Units)
    Table 100. South America Subcutaneous Allergy Immunotherapies Consumption Value by Country (2018-2023) & (USD Million)
    Table 101. South America Subcutaneous Allergy Immunotherapies Consumption Value by Country (2024-2029) & (USD Million)
    Table 102. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Quantity by Type (2018-2023) & (K Units)
    Table 103. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Quantity by Type (2024-2029) & (K Units)
    Table 104. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Quantity by Application (2018-2023) & (K Units)
    Table 105. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Quantity by Application (2024-2029) & (K Units)
    Table 106. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Quantity by Region (2018-2023) & (K Units)
    Table 107. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Quantity by Region (2024-2029) & (K Units)
    Table 108. Middle East & Africa Subcutaneous Allergy Immunotherapies Consumption Value by Region (2018-2023) & (USD Million)
    Table 109. Middle East & Africa Subcutaneous Allergy Immunotherapies Consumption Value by Region (2024-2029) & (USD Million)
    Table 110. Subcutaneous Allergy Immunotherapies Raw Material
    Table 111. Key Manufacturers of Subcutaneous Allergy Immunotherapies Raw Materials
    Table 112. Subcutaneous Allergy Immunotherapies Typical Distributors
    Table 113. Subcutaneous Allergy Immunotherapies Typical Customers
List of Figures
    Figure 1. Subcutaneous Allergy Immunotherapies Picture
    Figure 2. Global Subcutaneous Allergy Immunotherapies Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Subcutaneous Allergy Immunotherapies Consumption Value Market Share by Type in 2022
    Figure 4. High Concentration Examples
    Figure 5. Low Concentration Examples
    Figure 6. Global Subcutaneous Allergy Immunotherapies Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Subcutaneous Allergy Immunotherapies Consumption Value Market Share by Application in 2022
    Figure 8. Primary Immunodeficiency Examples
    Figure 9. Secondary Immunodeficiency Examples
    Figure 10. Others Examples
    Figure 11. Global Subcutaneous Allergy Immunotherapies Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Subcutaneous Allergy Immunotherapies Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Subcutaneous Allergy Immunotherapies Sales Quantity (2018-2029) & (K Units)
    Figure 14. Global Subcutaneous Allergy Immunotherapies Average Price (2018-2029) & (US$/Unit)
    Figure 15. Global Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global Subcutaneous Allergy Immunotherapies Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of Subcutaneous Allergy Immunotherapies by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Subcutaneous Allergy Immunotherapies Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 Subcutaneous Allergy Immunotherapies Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global Subcutaneous Allergy Immunotherapies Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America Subcutaneous Allergy Immunotherapies Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Subcutaneous Allergy Immunotherapies Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Subcutaneous Allergy Immunotherapies Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Subcutaneous Allergy Immunotherapies Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa Subcutaneous Allergy Immunotherapies Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global Subcutaneous Allergy Immunotherapies Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global Subcutaneous Allergy Immunotherapies Average Price by Type (2018-2029) & (US$/Unit)
    Figure 30. Global Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Application (2018-2029)
    Figure 31. Global Subcutaneous Allergy Immunotherapies Consumption Value Market Share by Application (2018-2029)
    Figure 32. Global Subcutaneous Allergy Immunotherapies Average Price by Application (2018-2029) & (US$/Unit)
    Figure 33. North America Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Application (2018-2029)
    Figure 35. North America Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America Subcutaneous Allergy Immunotherapies Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Application (2018-2029)
    Figure 42. Europe Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe Subcutaneous Allergy Immunotherapies Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific Subcutaneous Allergy Immunotherapies Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Application (2018-2029)
    Figure 61. South America Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America Subcutaneous Allergy Immunotherapies Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Application (2018-2029)
    Figure 67. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa Subcutaneous Allergy Immunotherapies Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa Subcutaneous Allergy Immunotherapies Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Subcutaneous Allergy Immunotherapies Market Drivers
    Figure 74. Subcutaneous Allergy Immunotherapies Market Restraints
    Figure 75. Subcutaneous Allergy Immunotherapies Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Subcutaneous Allergy Immunotherapies in 2022
    Figure 78. Manufacturing Process Analysis of Subcutaneous Allergy Immunotherapies
    Figure 79. Subcutaneous Allergy Immunotherapies Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
WOLW Pharma
Holister Stier
Leti

Related Reports

Global Subcutaneous Allergy Immunotherapies Supply, Demand and Key Producers, 2023-2029

Global Subcutaneous Allergy Immunotherapies Supply, Demand and Key Producers, 2023-2029

date 03 Mar 2023

date Pharma & Healthcare

The global Subcutaneous Allergy Immunotherapies market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Subcutaneous Allergy Immunotherapies Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Subcutaneous Allergy Immunotherapies Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Subcutaneous Allergy Immunotherapies market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Subcutaneous Allergy Immunotherapies Supply, Demand and Key Producers, 2024-2030

Global Subcutaneous Allergy Immunotherapies Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Pharma & Healthcare

The global Subcutaneous Allergy Immunotherapies market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Subcutaneous Allergy Immunotherapies

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>